Trials

A Pilot Study of Sequential ONCOS-102, an Engineered Oncolytic Adenovirus Expressing GMCSF, and Pembrolizumab in Patients with Advanced or Unresectable Melanoma Progressing

Cancer type: Melanoma

Phase: I

Principal Investigator: Nyakas Martha

Country: NO

Keywords: Norway, Oslo, oncolytic adenovirus, advanced or unresectable melanoma

Status: Open for inclusion

Link to Clinicaltrials.gov: https://clinicaltrials.gov/ct2/show/NCT03003676